Voluntis Strengthens Its Global Customer Support Services in Collaboration With Zendesk
Highly personalized support provided for patients and healthcare professionals using Voluntis digital therapeutics
Improved scalability of Voluntis operations by supporting the commercial rollout of the growing number of solutions co-developed with life sciences partners in new geographies
Regulatory News:
Voluntis (Paris:ALVTX) (Euronext Growth Paris, Ticker: ALVTX ISIN: FR0004183960)
a leader in digital therapeutics, today announces the upgrade of its global customer support infrastructure in collaboration with customer service software company Zendesk.
Thanks to the new collaboration, Voluntis will leverage Zendesk s capabilities to integrate and streamline the support services it provides for its pharma partners as part of the commercialization of co-developed digital therapeutics and in full compliance with applicable regulations.
Regulatory News: Voluntis (Paris:ALVTX) (Euronext Growth Paris, Ticker: ALVTX ISIN: FR0004183960), a leader in the field of digital therapeutics, announces that Bryan, Garnier Co, a leading pan-European
Share
All around the world the coronavirus pandemic has led to an uptick in digital healthcare delivery models. While telemedicine is often touted as the poster child of digital success in 2020, digital therapeutics (DTx) also emerged as a player on the global stage. What we are seeing is digital therapeutics, while they won’t directly treat COVID, they are really an integral component of this healthcare going forward. I think policymakers and payers increasingly over the year have understood that, Megan Coder, executive director of the Digital Therapeutics Alliance, said during a panel discussion at DTx West this morning.
Coder noted that in the United States, she saw policymakers go from barely understanding the field in February and March of 2020 to actively seeking out these technologies just a few months later.
This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Healthcare startups that had a breakout year in 2020 are poised to have an even better 2021, investors told Business Insider.
Startups, especially those focused on virtual care benefitted from being in the right place at the right time amid the global pandemic.
Business Insider interviewed dozens of venture capitalists and other private investors to learn which startups are poised to take off in 2021.
Looking back, 2020 will likely mark a sea change for healthcare startups.
Many startups saw a pandemic-sized opportunity and took advantage of new technology and newly agile hospitals and clinics to break into the notoriously difficult field.